A Study of Zetomipzomib (KZR-616) in Patients with Active Lupus Nephritis (PALIZADE) (clinicaltrials.gov) - Nov 19, 2024 - P2 | N=84 | Terminated | Sponsor: Kezar Life Sciences, Inc. | N=279 ➔ 84 | Trial completion date: Jul 2026 ➔ Nov 2024 | Suspended ➔ Terminated | Trial primary completion date: May 2026 ➔ Nov 2024; Sponsor Decision.
Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|